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Abstract 25 
Using a sequence based approach we previously identified an IncI1 CTX-M-1 plasmid, 26 
pIFM3791, on a single pig farm in the UK that was harboured by K. pneumoniae, 27 
Escherichia coli and Salmonella enterica serotype 4,5,12,i:-. To test the hypothesis that 28 
the plasmid had spread rapidly into these differing host bacteria we wished to assess 29 
whether the plasmid conferred a fitness advantage. To do this an IncI1 curing vector 30 
was constructed and used to displace the IncI1 CTX-M-1 plasmids from K. pneumoniae 31 
strain B3791 and several other unrelated IncI1 harbouring strains indicating the 32 
potential wider application of the curing plasmid. The IncI1 CTX-M-1 plasmid was re-33 
introduced by conjugation into the cured K. pneumoniae strain and also a naturally 34 
IncI1 plasmid free S. enterica serotype 4,5,12,i:-, S348/1.  Original, cured and 35 
complemented strains were tested for metabolic competence using BiologTM technology 36 
and in competitive growth, association to mammalian cells and biofilm formation 37 
experiments. The plasmid-cured K. pneumoniae strain grew more rapidly than either the 38 
original plasmid-carrying strain or plasmid-complemented strains in competition 39 
experiments. Additionally, the plasmid-cured strain was significantly better at respiring 40 
with L-sorbose as a carbon source and putrescine, γ-amino-n-butyric acid, L-alanine, L-41 
proline as a nitrogen sources. By contrast, no differences in phenotype were found when 42 
comparing plasmid harbouring and plasmid free S. enterica S348/11. In conclusion, the 43 
IncI1 curing vector successfully displaced multiple IncI plasmids. The IncI1 CTX-M1 44 
plasmid conferred a growth disadvantage upon K. pneumoniae, possibly by imposing a 45 
metabolic burden the mechanism of which remains to be determined.   46 
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Introduction 47 
Extended Spectrum β-Lactamases (ESBL) confer resistance to most penicillins and 48 
monobactams and, more significantly, the clinically important cephalosporins 49 
(Gniadkowski, 2001). The CTX-M class of ESBLs has become the most prevalent type 50 
isolated from clinical settings (Livermore et al., 2007), and is increasingly common in 51 
community and veterinary isolates (Batchelor et al., 2005; Pitout et al., 2005). 52 
Awareness of the potential spread of this resistance in livestock has increased (Horton et 53 
al., 2011). Furthermore, recent genome sequencing data of human and food animal 54 
Escherichia coli isolates from the Netherlands indicate that the dissemination of 55 
resistance across reservoirs is caused by the expansion of successful plasmid lineages 56 
(de Been et al., 2014). 57 
During a diagnostic investigation in 2009 into pig mortality related to diarrhoea 58 
on a single pig farm in the UK, CTX-M-1 harbouring Klebsiella pneumoniae, 59 
Escherichia coli and Salmonella of serotypes 4,5,12,i:- and Bovismorbificans were 60 
recovered. Genotyping methods suggested the dissemination of a common IncI1-CTX-61 
M-1 plasmid, which was demonstrated by sequencing a plasmid isolated from each of 62 
the bacterial species present in the farm. These plasmids, pIFM3791, pIFM3804 and 63 
pIFM3844 had been found to be identical, excepting a small number (n=7) of mutations 64 
(see supplementary data for Table S1) (Freire Martín et al., 2014). These findings 65 
prompted the question whether or not this plasmid conferred a fitness advantage to the 66 
host bacterium, possibly beyond the resistance phenotype. Plasmids may confer a 67 
selective advantage to their host even in the absence of antibiotic selective pressure as 68 
suggested by Enne et al. (2004).  The plasmids present in this farm may themselves 69 
confer a selective advantage, especially as there was no recent evidence of use of lactam 70 
based antibiotics on this farm. To assess this, our aim was to prepare plasmid bearing 71 
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and plasmid free isogenic strains for phenotypic testing and two approaches were used. 72 
One was to place the plasmids of interest in a common isogenic background. The other 73 
was to generate cured host strains for which a number of methods have been described. 74 
Commonly used methods include continuous non-selective passage or growth in the 75 
presence of sub-lethal concentrations of DNA intercalating agents, but both methods 76 
may accumulate mutations (Ferguson & Denny, 2007). Thus, for this study we opted for 77 
the use of incompatibility based curing following the observation that two plasmids 78 
bearing the same replicon cannot be stably maintained in a bacterium (Couturier et al., 79 
1988). Plasmid incompatibility based curing has been successfully employed for curing 80 
of plasmids (Hale et al., 2010; Tatsuno et al., 2001), but not as yet for IncI1 plasmids. 81 
Here we describe the construction of a curing tool for IncI1 CTX-M plasmids and then 82 
the phenotypic analyses of plasmid free and plasmid carrying strains. 83 
 84 
Materials and methods 85 
Bacterial strains and plasmids 86 
The strains and plasmids described in this study were either wild-type and originating 87 
from previous studies (Freire Martín et al., 2014; Horton et al., 2011; Randall et al., 88 
2012), commercially available strains and plasmids, or, in the case of pIFM26 (S1), a 89 
modification of previously described plasmid pAKE604 (El-Sayed et al., 2001), which 90 
differed from it only in the orientation of the restriction sites within its MCS. The 91 
strains were grown in LB medium and, when necessary for plasmid maintenance, in the 92 
presence of appropriate antibiotics.  93 
Generation of curing vector pIFM27 94 
Exponentially growing bacteria were made electrocompetent through successive water 95 
and glycerol washes. For molecular cloning, amplified PCR products were digested 96 
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using commercially available enzymes and ligated to digested vectors using standard 97 
techniques, a description of which has been included within the supplementary 98 
materials (S1). The final curing vector was named pIFM27 and it harboured negative 99 
selection gene sacB, resistance markers kanr, ampr and aac6-Ib and IncI1 plasmid 100 
replication down-regulator RNAI alongside its native promoter (Fig. 1). 101 
Plasmid conjugation 102 
Stationary, antibiotic free LB broth cultures of donor (50μl) and recipient (150μl) were 103 
mixed and overlaid on a polycarbonate 0.2μm filter placed on the centre of a LB agar 104 
plate and incubated at 37oC for 24hrs. The bacteria were washed with 2ml of PBS and 105 
transconjugants selected by plating on Rambach agar plates supplemented with 10μg/ml 106 
of tetracycline and 2μg/ml of cefotaxime. Tetracycline was chosen as the intended 107 
recipients had been shown to be resistant during extensive characterisation carried out 108 
as part of previous work (Freire Martín et al., 2014). Colonies of the appropriate colour 109 
(red for the S. enterica strains, purple for the K. pneumoniae strains) were re-streaked 110 
and checked for the presence of the incoming plasmid by CTX-M universal PCR and 111 
plasmid profiling. 112 
Characterization methods used for verification of curing, conjugation and strain 113 
identity 114 
Macro-restriction profiles of strains were obtained by XbaI Pulsed Field Gel 115 
Electrophoresis (PFGE) as described by the PulseNet network (Gerner-Smidt et al., 116 
2006). Electrophoresis conditions were 14°C at 6V/cm for 19.5h with switch times 117 
ranging from 2.2 to 54.2s of linear ramping for the K. pneumoniae strains and 2.2 to 118 
63.8s for the S. enterica strains. Gel images were analysed using of BioNumerics 119 
software (v.6.6; Applied Maths, Belgium). 120 
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Plasmid profiling was performed following the method of Kado and Liu (1981). As 121 
reference supercoiled DNA ladder (Sigma-Aldrich D5292), reference strain 39R861 and 122 
reference strain 20R764 were also run.  123 
A number of primers were also used to test for the presence of certain genes within the 124 
strains throughout the different stages of curing using PCR, as described in the results. 125 
See Table 1 for the primer sequences. The PCR ramping conditions were in every case 126 
25 cycles of 94oC for 30s, 60oC for 30s and 72oC for 1m. 127 
Phenotypic tests of plasmid burden by Biolog Phenotype Microarray 128 
BiologTM plates PM2 and PM3 were used following manufacturer’s instructions. 129 
BiologTM output data files were imported into R (http://www.R-project.org; R Core 130 
Team, R: A Language and Environment for Statistical Computing, R Foundation for 131 
Statistical Computing, Vienna, Austria, 2014) and the kinetic curves for each biological 132 
replicate were fitted using the Grofit package (Kahm et al., 2010). The features studied 133 
were: the area under the curve (AUC), the maximum value achieved (MaxV), and the 134 
fastest rate of increase (RateI).  135 
Competitive growth curves 136 
Competition experiments of plasmid-free vs. plasmid-harbouring strains were set up and 137 
carried out as previously described (Lenski et al., 1994). A sample of the competition 138 
mixture at time 0, and thereafter every 24hrs for 6 days, was serially diluted and plated 139 
on LB agar and LB agar supplemented with 2µg/ml of cefotaxime to obtain counts of 140 
total bacteria and of resistant bacteria, respectively. To calculate the selection rate the 141 
natural log of the ratio of plasmid-bearing/plasmid-free for each day was plotted for 142 
each competition. The selection rate was taken as the slope of the equation defining the 143 
line of best fit. Each competition was repeated four times and two tailed t-tests were 144 
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carried out to determine whether the mean selection rate for each pair of strains 145 
competed was significantly different from 0. 146 
Association of K. pneumoniae to cultured monolayers of mammalian cells 147 
The porcine intestinal epithelial cell line IPEC-J2 was used. Specifically, 2 day old cells 148 
cultured to confluency in 24 well plates were used. On the day of the assay, the culture 149 
medium was removed from the wells and the cells were washed twice with Hank’s 150 
balanced salts solution to remove residual antibiotics. The bacterial inocula were 151 
resuspended in Ham’s F12/DMEM supplemented with 2% mannose and delivered in 152 
volumes of 1ml at a density of ~107 CFU/ml per well in triplicate. The plates were then 153 
incubated for 1hr in an atmosphere of 5% CO2 at 37oC with 100% humidity. After 154 
incubation, the bacterial inocula were removed and the wells washed three times with 155 
HBSS. After washing, the cells were disrupted by addition of 1% Triton-X 100 (in PBS) 156 
with mechanical stirring followed by serial dilution and plating on LB agar (Favre-157 
Bonte et al., 1999).  158 
Association and invasion of S. enterica to cultured monolayers of mammalian cells 159 
Association of S. enterica was evaluated in the same manner as above with minor 160 
differences. Specifically, the bacterial inocula were delivered as 1ml of ~3.5x107 161 
CFU/ml suspended in Ham’s F12/DMEM with a co-incubation step of 2hr. A second 162 
plate was set up identically and used for the enumeration of intracellular bacteria 163 
(invasion). After co-incubation and washing, the monolayers were overlayed with 164 
Ham’s F12/DMEM supplemented with 150mg/L colistin and incubated for 90min. The 165 
antibiotic containing medium was removed and the wells were washed three times with 166 
HBSS. After washing, the cells were disrupted and the bacteria were enumerated as 167 
described above (Searle et al., 2009). 168 
Biofilm formation 169 
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Stationary bacteria were seeded at 0.05OD570 and cultured statically in LB (K. 170 
pneumoniae) or LB without salt (S. enterica) within triplicate wells in microplates for 171 
24h at 25o C and 37oC. The culture was discarded, the wells were washed 3 times with 172 
PBS and 130μl of 1% crystal violet was added to the wells and incubated at room 173 
temperature for 30 min. The crystal violet solution was then discarded and the wells 174 
were washed 4 times with distilled water. To solubilise the bound crystal violet, 130μl 175 
of ethanol/acetone (70/30 v/v) was added to the wells and after 10min the OD570 176 
determined (Woodward et al., 2000). The experiments were carried out three times for 177 
each strain and temperature.  178 
Statistical analysis of phenotypic assays 179 
For each of the measured phenotypes statistical analysis to compare strains was 180 
performed using the triplicate measurements for each strain as input to a one way 181 
ANOVA test. Any ANOVA test having a P-value <0.05, indicating that there is a 182 
difference in feature values between at least two strains, was followed by a Tukey’s 183 
HSD post-hoc test, where a P-value < 0.05 for a specific strain comparison denoted a 184 
significant difference. For the Biolog experiment this analysis was carried out in R 185 
whereas for the remaining experiments statistical analysis was carried out using 186 
GraphPad Prism 5. 187 
 188 
Results 189 
Construction of the IncI1 curing plasmid: selection of targets and vector 190 
The DNA sequences of IncI1-CTX-M-1 plasmids from K. pneumoniae, E. coli and S. 191 
enterica 4,5,12;i;- identified during a pig farm investigation (Freire Martín et al., 2014) 192 
were analysed. The aim of this analysis was to identify genes involved in replication 193 
and maintenance in order to target them with the curing vector. A single replicon was 194 
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identified as well as addiction system pndA/C. In the first instance, the RNA gene, 195 
RNAI, which controls the copy number in IncI1 plasmids by translational regulation of 196 
replication initiator repZ (Praszkier & Pittard, 2005), was amplified by PCR and cloned 197 
into suicide vector pIFM26 (see supplementary material). This vector is not stable in the 198 
absence of selection which, together with the presence of negative selection marker 199 
sacB (confers sucrose sensitivity to Gram negative organisms), would enable recovery 200 
of vector free clones by growth on antibiotic-free sucrose-containing media (Hale et al., 201 
2010).  202 
K. pneumoniae strain B3791 is naturally resistant to both kanamycin and 203 
ampicillin, the markers present in pIFM26. An alternative selectable marker was 204 
required and so an amikacin resistance determinant aac6-Ib was cloned from plasmid 205 
CB01 and inserted to create pIFM27 (pIFM26::RNAI::aac6-Ib) (Fig. 1). CB01 was a 206 
wild type plasmid isolated by C. Boinet (unpublished thesis). 207 
Curing K. pneumoniae strain B3791 of IncI1 CTX-M plasmid by transformation 208 
with pIFM27 209 
To validate the use of curing vector pIFM27 curing tests were performed with 210 
wild type strains carrying IncI1-CTX-M-1 plasmids from sources other than the farm 211 
pertaining to this study. LREC215, a commensal E. coli isolated from a broiler chick 212 
(Horton et al., 2011) and LREC447, an avian pathogenic E. coli isolated from a broiler 213 
(Randall et al., 2012), were confirmed by PCR to carry a CTX-M group 1 gene on an 214 
IncI1-γ plasmid and to be sensitive to kanamycin, a strong selectable marker present in 215 
pIFM27. Electrocompetent cells were transformed with curing vector pIFM27 with 216 
selection on kanamycin (50mg/L). Four colonies from each transformation were tested 217 
for the acquisition of pIFM27 by vector PCR. 100% of the colonies tested were shown 218 
to be sensitive to cefotaxime and no longer carried their respective CTX-M plasmids as 219 
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shown by both CTX-M PCR and plasmid profiling. pIFM27 was excluded from the 220 
transformants by culture in LB followed by recovery on LB agar supplemented with 5% 221 
sucrose. Eight colonies recovered on sucrose supplemented agar for each strain were 222 
tested by vector PCR and plasmid profiling which showed that the vector had been 223 
successfully excluded. As the presence of RNAI in this vector was sufficient for the 224 
exclusion of the target plasmid there was no need to pursue the making of a pndA/C 225 
harbouring construct. 226 
In the case of K. pneumoniae B3791 curing vector pIFM27 was electroporated 227 
with selection on amikacin 2mg/L. This resulted in forty putative transformant colonies 228 
of which three had acquired pIFM27, as confirmed by vector PCR. The remainder were 229 
most likely spontaneous resistant mutants which is possible given the recipient strain 230 
harboured another aminoglycoside resistance gene, a family of compounds against 231 
which cross-resistance is known to occur (Shaw et al., 1993). The three genuine 232 
transformants were sensitive to cefotaxime (2mg/L) and had lost pIFM3791, as verified 233 
by CTX-M PCR and plasmid profiling. pIFM27 was excluded from these three by 234 
culture on LB agar supplemented with 5% sucrose. Six randomly selected sucrose 235 
resistance derivatives from each transformant were negative for pIFM27 by PCR, their 236 
XbaI PFGE banding patterns were all highly similar if not identical to that of B3791 and 237 
plasmid profiles showed loss of a ~8kb plasmid, namely pIFM27. The remaining native 238 
plasmids present in B3791 remained unaffected throughout the curing process (Fig. 2). 239 
Collectively, these data indicated that curing vector pIFM27 excluded the IncI1 plasmid 240 
from strain B3791. One cured derivative, designated CL32, was taken forward for 241 
further analysis. The curing of an E. coli and a Salmonella 4,5,12,i:- originally isolated 242 
from the same farm as K. pneumoniae B3791 (Freire Martín et al., 2014) was also 243 
attempted. This was, however, unsuccessful due to high levels of resistance to multiple 244 
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antibiotic and we did not investigate other selectable markers in this proof of concept 245 
study.  246 
 247 
Re-introduction of the IncI1 CTX-M1 plasmids into cured K. pneumoniae, strain 248 
CL32. 249 
Having prepared CL32, the plasmid cured derivative of K. pneumoniae B3791, 250 
the last step in constructing strains for plasmid phenotype comparisons was to re-251 
introduce the outbreak plasmids into CL32. Solid surface mating conjugations were set 252 
up with strains CL32 as recipient and laboratory strains of E. coli (NEB10iβ) 253 
harbouring pIFM3791 (isolated from K. pneumoniae), pIFM3904 (isolated from E. coli)  254 
and pIFM3844 (isolated from Salmonella 4,5,12:i:-), respectively, as donors. DNA 255 
sequence analysis had previously shown these to plasmids to be very similar to each 256 
other except for a small number of SNPs. As part of this work e wished to test whether 257 
these differences represented adaptations to the harbouring species (Freire Martín et al., 258 
2014). 259 
Transconjugants were selected by plating on Rambach agar supplemented with 260 
tetracycline at 10μg/ml, which selected for CL32, and cefotaxime at 2μg/ml, which 261 
selected for the incoming plasmid. Transconjugant colonies were sub-cultured and 262 
tested by PCR using the CTX-M universal primers (Table 1) and by plasmid profiling 263 
(Fig. 3) and the presence of a plasmid of ~100kb was confirmed in transconjugants of 264 
CL32 (Table 2).  265 
 266 
Phenotypic impact of plasmid carriage upon K. pneumoniae B3791 267 
In growth competition studies, strain CL32 outcompeted K. pneumoniae strain B3791 268 
(P=0.08), CL32-pIFM3791 (P<0.05), CL32-pIFM3804 (P<0.05) and CL32-pIFM3844 269 
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(P<0.05). A representative example of the data is shown in Fig. 4 and the summary of 270 
the data in Table 3. For K. pneumoniae B3791 and its cured and complemented 271 
derivatives no differences in association to IPEC-J2 monolayers were found. Crystal 272 
violet biofilm assays performed at 25oC and 37oC found no differences when comparing 273 
plasmid-free to plasmid-carrying strains.  274 
In order to investigate subtler impacts in the metabolism of the strain caused by 275 
plasmid carriage, Phenotype Microarrays (BiologTM) were performed on wild type K. 276 
pneumoniae strain B3791, its IncI1 plasmid cured derivative CL32 and complemented 277 
strain CL32-pIFM3791. There were four compounds for which one measurable 278 
parameter of respiration for the plasmid free strain CL32 was significantly higher (P-279 
value <0.05) than B3791 and CL32-pIFM3791 (Table 4). These were rate of increase 280 
(RateI) on L-sorbose as a carbon source and maximum value achieved (MaxV) on 281 
putrescine, γ-Amino-N-Butyric and Ala-Gly dipeptide as nitrogen sources. 282 
Using caproic acid, 4-hydroxy benzoic acid and putrescine as carbon sources 283 
there were significant differences between CL32 and B3791 or between CL32 and 284 
CL32-pIFM3791. For L-alanine, L-proline and L-threonine although CL32 was better 285 
able to respire on these compounds than the other two strains the difference was only 286 
significant when compared to plasmid-complemented strain CL32-pIFM3791. Finally, 287 
for dipeptide Ala-Thr significant differences were found for two different measures of 288 
growth, MaxV and AUC, although, the comparisons differed for each measure. Whilst 289 
the AUC for CL32 was significantly different only from CL32-pIFM3791, for MaxV all 290 
three comparisons revealed significant differences (Table 4). 291 
 292 
Effect of plasmid carriage on Salmonella 4,5,12:i:- strain S348/11 293 
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Having demonstrated the phenotypic impact of pIFM3791 upon K. pneumoniae, the 294 
question arose as to whether similar phenotypic impacts might occur in other Gram 295 
negative bacteria. We had previously noted that E. coli and Salmonella 296 
Bovismorbificans and 4,5,12:i:- from the same farm carried pIFM3791-like plasmids, 297 
which however could not be cured due to problems with cross-resistance. For this 298 
reason cefotaxime-sensitive Salmonella 4,5,12:i:- originating from the original farm 299 
were screened by PFGE, plasmid profiling, susceptibility testing and CTX-M PCR. An 300 
isolate designated S348/11 was identified which was identical to the Salmonella 301 
4,5,12:i:- by these measures except for the lack of carriage of a pIFM3791-like plasmid. 302 
Plasmid pIFM3791was introduced by conjugation into S348/11 and the phenotype of 303 
transconjugants was tested as described above. The presence of the plasmid did not 304 
affect competitive growth of the strains, their association and invasion of monolayers of 305 
mammalian cell line IPEC-J2, or their ability to form biofilm. 306 
 307 
Discussion 308 
PFGE and PCR tests confirmed curing plasmid pIFM27 successfully excluded IncI1 309 
CTX-M plasmids from K. pneumoniae B3791, and other unrelated strains with 100% 310 
efficiency. We showed also that the use of the curing plasmid could be extended by 311 
incorporation of alternative resistance markers demonstrating that this approach has 312 
wide applications dependent upon the incompatibility and selectable marker genes 313 
cloned. Here, limited selectable markers precluded use in other multiple antibiotic 314 
resistant strains. However, this should no longer be a major obstacle due to the presence 315 
of restriction sites flanking the resistance cassette allowing for easy exchange of 316 
markers. 317 
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Using cured derivative CL32 for phenotypic comparisons carried the risk that 318 
differences may be caused by the curing process hence complemented CL32 derivatives 319 
were also used. Plasmid cured CL32 out-competed both wild type and plasmid 320 
complemented strains, which themselves behaved in essentially the same manner 321 
suggesting a fitness burden was imposed by carriage of the test plasmids. In contrast, a 322 
recent study of an ST7 IncI1-CTX-M-1 plasmid isolated from broilers in the 323 
Netherlands found that its carriage did not impose a burden on the growth of its 324 
Escherichia coli host (Fischer et al., 2014) although previous findings suggest plasmids 325 
can slow down the growth of naïve hosts (Lee & Edlin, 1985; Zünd & Lebek, 1980). In 326 
the case of pIFM3791 it may have been recently acquired by K. pneumoniae and thus, 327 
co-evolution between plasmid and host, which is known to ameliorate growth 328 
disadvantage (Bouma & Lenski, 1988), may have not taken place by the time of 329 
isolation on the farm. Other reasons for the differences in behaviour could be caused by 330 
the actual sequence of the Dutch plasmid, as it displayed a different pMLST sequence 331 
type than that of pIFM3791 and its sequence is otherwise unknown.  332 
We did not investigate alternative selection markers and this precluded the construction 333 
of a Salmonella 4,5,12:i:- plasmid cured derivative. As such, we introduced pIFM3791, 334 
pIFM3804 and pIFM3844 into strain Salmonella 4.5.12:i- S348/11 which was a plasmid 335 
free strain from the same farm. Given the available data, S348/11 was highly similar to 336 
the original strain harbouring a pIFM3791 like plasmid, but it cannot be ruled out that it 337 
may have in the past harboured one such plasmid, and already be somewhat adapted to 338 
its carriage. Conversely, highly related versions of the plasmid were originally found in 339 
E. coli and Salmonella 4,5,12:i:- strains as well as K. pneumoniae. If the plasmid was 340 
introduced by a Salmonella 4,5,12:i:- strain into a K. pneumoniae strain this could also 341 
account for a degree of pre-existing plasmid adaption to S348/11 but not B3791. This is 342 
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supported by previous description of in vitro adaptation of a plasmid genome resulting 343 
in the amelioration of the fitness burden imposed upon its host (Modi & Adams, 1991).  344 
 Another interesting finding was the ability of CL32 to respire more efficiently 345 
than the other two strains on ten substrates: K. pneumoniae B3791 and CL32-pIFM3791 346 
behaved similarly giving confidence that plasmid pIFM3791 did impact metabolism 347 
although sequence analysis did not suggest any obvious gene candidates. Nevertheless 348 
many genes of unknown function may contribute and future transcriptional and targeted 349 
mutagenesis studies may resolve the mechanisms behind the phenotypes. Whether the 350 
suppression of respiratory activity using L-sorbose as a carbon source and putrescine, -351 
amino-N-butyric acid and dipeptide Ala-Gly as nitrogen sources impacts 352 
epidemiologically is worthy of consideration. Of importance is the identification of 353 
specific metabolically-based burdens mediated by the plasmid on K. pneumoniae which 354 
could be explained if expression of plasmid genes diverts resources away from the 355 
transcription of metabolic pathways involved in the growth under nutrient limiting 356 
conditions. Transcriptional interference mediated by integrated plasmids has been noted 357 
before (Zagaglia et al., 1991).  358 
Collectively, these data show that the effect that plasmid pIFM3791 has on its host is 359 
highly dependent on that host’s make up. Salmonella 4,5,12:i:- strain 348/11 was better 360 
able to carry the outbreak plasmids than the plasmid in K. pneumoniae strain B3791. 361 
Given its similarity to plasmid bearing isolates it is possible S348/11 is a naturally cured 362 
strain and adapted to the burdens imposed by the plasmid. Additionally, the experiments 363 
here also show that whether an effect is detectable or not will depend on the exact 364 
aspect of fitness that is being measured. The implication of these findings for the 365 
reversal of antimicrobial resistance is that even if there is a fitness cost for a certain 366 
strain of pathogenic bacteria, as long as there are others in its environment for which 367 
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such cost does not exist, and given the mobility of conjugative plasmids, once the 368 
selection pressure is imposed by means of the antibiotic, the plasmid can spread again. 369 
For this reason, it would have been interesting to have carried out the experiments with 370 
E. coli strains isolated from the farm. E. coli are often found to be harmless 371 
commensals, and if it was found that plasmid carriage is either beneficial or neutral for 372 
them, this could further lend weight to the idea that plasmids are maintained by certain 373 
strains and that are then  taken up by other strains in times of selective pressure.  374 
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Legends 473 
Figure 1: Genetic map of IncI1 curing vector pIFM27. The features coloured in black 474 
represent genetic structures already present in vector pIFM26 whilst the features 475 
coloured in grey are those added in this study. 476 
 477 
Figure 2: Plasmid profiling DNA gel electrophoresis of B3791, its pIFM27 478 
transformant derivatives CL28 and, pIFM27 free derivatives CL31 and CL32. 20R764 479 
is a reference plasmid free E. coli for identification of the chromosomal DNA band 480 
plasmids of B3791 and its derivatives. The band of approximately 8kb in CL28 481 
corresponds to the introduced pIFM27 curing vector. In lanes CL28 to CL32 the native 482 
CTX-M IncI1 p3791 has been lost. 483 
 484 
Figure 3: a) Plasmid profiling of S348/11 and its outbreak plasmid harbouring 485 
transconjugants. Plasmid profiling DNA gel electrophoresis of strain S348/11 and its 486 
outbreak plasmid carrying derivatives. 20R764 is a reference plasmid free E. coli for 487 
identification of the chromosomal DNA band. 39R861 is a reference strain carrying four 488 
plasmids of known sizes as labelled. Strain S348/11 carries no plasmids as shown in this 489 
gel, its transconjugants have acquired a plasmid of around 100kb, circled blue. b) 490 
Plasmid profiling of CL32 transconjugants complemented with the outbreak 491 
plasmids. Plasmid profiling DNA gel electrophoresis of strain CL32 transconjugants. 492 
T91-3 plasmid DNA has been included as a reference of the outbreak plasmid size 493 
(circled red). 20R764 is a reference plasmid free E. coli for identification of the 494 
chromosomal DNA band. 39R861 is a reference strain carrying four plasmids of known 495 
sizes as labelled. All transconjugants have acquired a plasmid of around 100kb, circled 496 
blue.  497 
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 498 
Figure 4: Representative example of a competition experiment of strain CL32 vs. 499 
B3791. The loge of the ratio of plasmid bearing over plasmid free organisms on each 500 
day has been plotted. The negative slope of the line of best fit denotes that B3791 is 501 
being outcompeted by CL32. 502 
  503 
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Table 1: Primers used in this study 504 
Primer Sequence 
RNAFW TCTAGAATATCTCGAGTGCACAGGGTTGAATCTC 
RNARV GGATCCTGTTCCGGAAGCCATAAA 
M13FW GTAAAACGACGGCCAG 
M13RV CAGGAAACAGCTATGAC 
PRE-MCS GCGATTAAGTTGGGTAACG 
aac6'IbFW GAATTCATGAGCAACGCAAAAACA 
aac6'IbRV GAATTCTTAGGCATCACTGCGTGT 
 505 
Table 2: List of plasmid complemented strains of CL32 and S348/11 as well as 506 
plasmid donor lab strains T91a, T04a and T44a. 507 
 508 
Strain Parent Species CTX-plasmid 
T91a NEB10-beta E. coli pIFM3791 
T04a NEB10-beta E. coli pIFM3804 
T44a NEB10-beta E. coli pIFM3844 
CL32-pIFM3791 CL32 K. pneumoniae pIFM3791 
CL32-pIFM3804 CL32 K. pneumoniae pIFM3804 
CL32-pIFM3844 CL32 K. pneumoniae pIFM3844 
S348/11 NA S. enterica NA 
S348/11-pIFM3791 S348/11 S. enterica pIFM3791 
S348/11-pIFM3804 S348/11 S. enterica pIFM3804 
S348/11-pIFM3844 S348/11 S. enterica pIFM3844 
  509 
Table 3: Effect of plasmid carriage on the competitive fitness of strains B3791 and 510 
S348/11 511 
Plasmid-less Plasmid-carrying Selection rate P-value 
CL32 
B3791 -0.29 0.08 
CL32-pIFM3791 -0.19 0.009 
CL32-pIFM3804 -0.22 0.011 
CL32-pIFM3844 -0.27 0.006 
S348/11 
S348/11-pIFM3804 -0.01 0.954 
S348/11-pIFM3844 0.01 0.957 
 512 
Competition experiment results (Selection Rate) and their statistical significance as 513 
assessed by a two tailed T test (P value). Highlighted in grey are those results 514 
considered to be significantly different from no selection (P<0.05). 515 
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Table 4: Effect of plasmid carriage on the metabolism of K. pneumoniae B3791 as assessed by Phenotype Microarray Biolog. 516 
Compound (Plate, Well) Feature Strain order 
P values of comparisons by Tukey's HSD 
CL32 vs. B3791 CL32-pIFM3791 vs. B3791 CL32::pIFM3791 vs. CL32 
L-Sorbose (PM2, D04) RateI CL32 > CL32-pIFM3791 > B3791 0.009 0.974 0.012 
Caproic acid (PM2, E02) 
MaxV CL32 > CL32-pIFM3791 > B3791 0.013 0.145 0.194 
AUC CL32 > CL32-pIFM3791 > B3791 0.031 0.430 0.164 
4-Hydroxy Benzoic Acid (PM2, E07) RateI CL32 > B3791 > CL32-pIFM3791 0.159 0.174 0.013 
Putrescine (PM2, H08) 
RateI CL32 > B3791 > CL32-pIFM3791 0.072 0.904 0.042 
MaxV CL32 > CL32-pIFM3791 > B3791 0.033 0.736 0.085 
AUC CL32 > CL32-pIFM3791 > B3791 0.029 0.679 0.082 
L-Alanine(PM3, A07) MaxV CL32 > B3791 > CL32-pIFM3791 0.165 0.472 0.035 
L-Proline (PM3, B09) MaxV CL32 > B3791 > CL32-pIFM3791 0.104 0.566 0.028 
L-Threonine (PM3, B11) 
MaxV CL32 > B3791 > CL32-pIFM3791 0.054 0.464 0.012 
AUC CL32 > B3791 > CL32-pIFM3791 0.098 0.526 0.024 
Putrescine (PM3, D11) MaxV CL32 > B3791 > CL32-pIFM3791 0.029 0.456 0.007 
γ-Amino-NButyric Acid (PM03, G08) MaxV CL32 > CL32-pIFM3791 > B3791 0.026 0.991 0.030 
Ala-Gly (PM3, H04) MaxV CL32 > B3791 > CL32-pIFM3791 0.026 0.768 0.012 
Ala-Thr (PM3, H07) 
MaxV CL32 > B3791 > CL32-pIFM3791 0.025 0.033 0.001 
AUC CL32 > B3791 > CL32-pIFM3791 0.236 0.238 0.024 
 517 
Listed are the compounds for which significant differences in their respiration were found for at least one of the features tested. Results that 518 
reach statistical significance have been highlighted in grey. 519 
* MaxV = maximum value achieved, RateI = fastest rate of increase, AUC = area under the curve.520 
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SUPPLEMENTARY MATERIAL 1 
All molecular biological methods including DNA extraction, measurement of DNA purity 2 
and concentration, PCR, restriction digestion of DNA, agarose gel electrophoresis, ligation, 3 
transformation, electroporation and selection followed standard procedures(Sambrook, J., E. 4 
F. Fritsch, n.d.) and manufacturer’s conditions for use of reagents. Sequencing reactions were 5 
carried out by the AHVLA Central Sequencing Unit. 6 
 7 
Construction of IncI1 curing vector plasmid pIFM27 RNAI1 aac6-Ib 8 
Primers were designed to amplify the RNAI gene along with its native promoter with 9 
tails on both forward (RNAIFW), and reverse (RNARV) primers (Table 1) that introduced 10 
XbaI and XhoI sites to the 5’ and a BamHI site to the 3’ of the RNAI gene. Using plasmid 11 
pIFM3804 DNA as template, the PCR generated a product of the correct size that blunt end 12 
cloned into pCR-Blunt. Plasmid DNA extracted from four transformants was digested using 13 
XbaI and BamHI which confirmed the presence of an insert of the predicted size and 14 
sequencing with insert flanking primers (M13FW and M13RV) showed complete integrity of 15 
RNAI.  16 
Plasmid DNA from one transformant was digested with XbaI and BamHI and the 17 
RNAI insert was gel purified and ligated with vector pIFM26, previously digested with XbaI 18 
and BamHI. pIFM26 was identical to previously described pAKE604,(El-Sayed et al., 2001) 19 
with a minor modification to invert its multiple cloning site. The ligated DNA was used to 20 
transform E. coli DH5α with ampicillin selection (100mg/L). To verify the constructs, 21 
plasmid DNA extracted from three well isolated transformants was digested with BglII and 22 
XhoI to confirm the predicted total and fragment size of the plasmid and was used as target 23 
for PCR and sequencing using RNAI-FW and Pre-MCS primers (Table 1). One transformant 24 
designated CL19 was retained for further work. 25 
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As the outbreak strains were already resistant to kanamycin and ampicillin, the 26 
markers present on pIFM26, an alternative resistance marker, amikacin, was chosen for 27 
inclusion in the curing vector. The amikacin resistance gene aac6’-Ib was amplified using 28 
forward and reverse primers, aac6’-IbFW and aac6’-IbFW that included EcoRI tails (Table 29 
1), using as target the wild type plasmid isolated by C. Boinet as part of her PhD studies 30 
(Phenotypic and genotypic analysis of blaCTX-M encoding plasmids isolated from bovine E. 31 
coli samples in the United Kingdom: Royal Holloway, University of London). The aac6’-Ib 32 
gene product was cloned into pCR-Blunt in E. coli NEB5α with selection for kanamycin 33 
(50mg/L). Plasmid DNA extracted from five transformants was used in PCR with primers 34 
flanking the insertion site (M13FW and M13RV) to confirm presence of the insert (expected 35 
~800bp band) and the product integrity was confirmed by sequence analysis. One 36 
transformant designated CL25 was retained for further work. 37 
Plasmid DNA extracted from CL25 was digested with EcoRI and the aac6’-Ib 38 
fragment was cloned into the EcoR1 site of pIFM19 DNA in E. coli NEB5α with selection for 39 
transformants resistant to ampicillin (100mg/L). Only one colony was found and PCR 40 
analysis using primer pairs aac6’-IbFW and Pre-MCS and aac6’-IbRV and Pre-MCS 41 
confirmed the correct orientation of the insert with respect to the LacZ promoter to drive its 42 
expression. The resulting strain was named CL27 and its plasmid pIFM27 (Figure 1). 43 
Table S1: Sequence differences in outbreak plasmids pIFM3791, pIFM3804 and 44 
pIFM3844  45 
Position in pIFM3804 
Sequence 
Gene Effect 
pIFM3791 pIFM3804 pIFM3844 
6148 G G A ISCR2 
serine to phenylalanine  
in pIFM3844 
10994 CG  -G  - - outside coding region NA 
19884 G  - G ybaA 
frameshift (in pIFM3791  
and pIFM3844) 
24941 A  - A hypothetical protein 
frameshift (in pIFM3791  
and pIFM3844) 
56570 A  - A hypothetical protein 
frameshift (in pIFM3791  
and pIFM3844) 
57253 T  - T outside coding region NA 
58328 T  - T exc 
frameshift (in pIFM3791  
and pIFM3844) 
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